Skip to main content

Table 4 Multivariate analysis of the survival of IPSS-R lower-risk subjects with respect to micro-megakaryocytes

From: A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

 

HR

95 % CI

P value

Age (year)

  

0.024

 ≥60

1.856

1.086–3.171

 

 <60*

1.0

  

Gender

  

0.185

 IPSS-R

  

0.026

 Very-low

0

0–6.17E272

 

 Low

0.478

0.280–0.816

 

 Intermediate*

1.0

  

Micro-megakaryocytes (%)

  

<0.01

 ≥25

2.806

1.509–5.218

 

 <25*

1.0

  
  1. * The reference
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us